Biblio

Export 1382 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
Journal Article
M. Cushman, Callas, P. W., McClure, L. A., Unverzagt, F. W., Howard, V. J., Gillett, S. R., Thacker, E. L., and Wadley, V. G., “N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 497-503, 2016.
C. Sassi, Capozzo, R., Gibbs, R., Crews, C., Zecca, C., Arcuti, S., Copetti, M., Barulli, M. R., Brescia, V., Singleton, A. B., and Logroscino, G., “A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.
H. Guo, Sun, S., Yang, Y., Ma, R., Wang, C., Zheng, S., Wang, X., and Li, G., “A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.”, J Alzheimers Dis, vol. 101, no. 3, pp. 923-936, 2024.
C. Theunis, Adolfsson, O., Crespo-Biel, N., Piorkowska, K., Pihlgren, M., Hickman, D. T., Gafner, V., Borghgraef, P., Devijver, H., Pfeifer, A., Van Leuven, F., and Muhs, A., “Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.”, J Alzheimers Dis, vol. 56, no. 2, pp. 585-599, 2017.
D. Castro Araújo, Veloso, A. Alonso, Gomes, K. Braga, de Souza, L. Cruz, Ziviani, N., and Caramelli, P., “A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 549-561, 2022.
J. Marín-Muñoz, Noguera-Perea, M. Fuensanta, Gómez-Tortosa, E., López-Motos, D., Antequera-Torres, M., Martínez-Herrada, B., Manzanares-Sánchez, S., Vivancos-Moreau, L., Legaz-García, A., Del Arroyo, A. Rábano- Gu, and Antúnez-Almagro, C., “Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 73-8, 2016.
C. M. Callahan, Apostolova, L. G., Gao, S., Risacher, S. L., Case, J., Saykin, A. J., Lane, K. A., Swinford, C. G., and Yoder, M. C., “Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 75, no. 3, pp. 959-969, 2020.
E. A. Tanifum, Ghaghada, K., Vollert, C., Head, E., Eriksen, J. L., and Annapragada, A., “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
A. Popelová, Pražienková, V., Neprašová, B., Kasperová, B. Judita, Hrubá, L., Holubová, M., Zemenová, J., Blum, D., Železná, B., Galas, M. - C., Kuneš, J., and Maletínská, L., “Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1725-1736, 2018.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., “Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
T. Panagaki, Gengler, S., and Holscher, C., “The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model.”, J Alzheimers Dis, vol. 66, no. 1, pp. 195-218, 2018.
D. Brici, Götz, J., and Nisbet, R. M., “A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.”, J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
H. Leinonen, Lipponen, A., Gurevicius, K., and Tanila, H., “Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 51, no. 1, pp. 21-6, 2016.
L. Calderón-Garcidueñas, Mukherjee, P. S., Waniek, K., Holzer, M., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Calderón-Garcidueñas, A., Franco-Lira, M., Reynoso-Robles, R., González-Maciel, A., and Lachmann, I., “Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1437-1451, 2018.
M. Cations, Draper, B., Low, L. - F., Radford, K., Trollor, J., Brodaty, H., Sachdev, P., Gonski, P., Broe, G. Anthony, and Withall, A., “Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1747-1758, 2018.
O. Keret, Shochat, T., Steiner, I., and Glik, A., “Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 877-884, 2018.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
S. M. G. Cioffi, Galimberti, D., Barocco, F., Spallazzi, M., Fenoglio, C., Serpente, M., Arcaro, M., Gardini, S., Scarpini, E., and Caffarra, P., “Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.”, J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
S. M. G. Cioffi, Galimberti, D., Barocco, F., Spallazzi, M., Fenoglio, C., Serpente, M., Arcaro, M., Gardini, S., Scarpini, E., and Caffarra, P., “Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.”, J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
M. K. Lupton, Benyamin, B., Proitsi, P., Nyholt, D. R., Ferreira, M. A., Montgomery, G. W., Heath, A. C., Madden, P. A., Medland, S. E., Gordon, S. D., Lovestone, S., Tsolaki, M., Kloszewska, I., Soininen, H., Mecocci, P., Vellas, B., Powell, J. F., Bush, A. I., Wright, M. J., Martin, N. G., and Whitfield, J. B., “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
M. K. Lupton, Benyamin, B., Proitsi, P., Nyholt, D. R., Ferreira, M. A., Montgomery, G. W., Heath, A. C., Madden, P. A., Medland, S. E., Gordon, S. D., Lovestone, S., Tsolaki, M., Kloszewska, I., Soininen, H., Mecocci, P., Vellas, B., Powell, J. F., Bush, A. I., Wright, M. J., Martin, N. G., and Whitfield, J. B., “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
G. D. Manocha, Ghatak, A., Puig, K. L., Kraner, S. D., Norris, C. M., and Combs, C. K., “NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 775-787, 2017.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., “New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
D. Michalski, Hofmann, S., Pitsch, R., Grosche, J., and Härtig, W., “Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.”, J Alzheimers Dis, vol. 59, no. 2, pp. 655-674, 2017.

Pages